Volume 130, Issue 1, Pages (July 2013)

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Volume 144, Issue 1, Pages (January 2017)
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.
Thomas J. Birdas, MD, Richard P. M
Volume 150, Issue 1, Pages (July 2018)
Are patients willing to travel for better ovarian cancer care?
Volume 148, Issue 1, Pages (January 2018)
L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L
Volume 148, Issue 1, Pages (January 2018)
A. Melamed, E. J. Diver, A. A. Gockley, E. M. Hinchcliff, L
Pain in cancer survivors; filling in the gaps
Volume 145, Issue 2, Pages (May 2017)
Volume 138, Issue 1, Pages (July 2015)
APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26
Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.
Volume 144, Issue 2, Pages (February 2017)
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians)  Carsten Nieder, Thomas A.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Volume 135, Issue 1, Pages (October 2014)
M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns
Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer  Masatsugu Hamaji,
Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei 
Volume 148, Issue 1, Pages (January 2018)
Volume 136, Issue 2, Pages (February 2015)
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Supportive care plans: Linking patient-reported outcomes to evidence-based supportive care across the cancer continuum  E.E. Stevens, J.N. Bottsford-Miller,
Volume 142, Issue 3, Pages (September 2016)
National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence  J. Chino, J.R. Foote,
Photodynamic Therapy for Early Stage Central Type of Lung Cancer
Thomas J. Birdas, MD, Richard P. M
Volume 146, Issue 1, Pages (July 2017)
Volume 152, Issue 1, Pages (January 2019)
Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer  E.N. Prendergast,
K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani
Volume 152, Issue 1, Pages (January 2019)
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Volume 143, Issue 2, Pages (November 2016)
Laparoscopic staging for stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base  A. Melamed, J.T. Clemmer, N.L. Keating, J.D. Wright,
I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M
Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum  A. Ellis, M.K. Frey, L.M. Koontz, S. Shyne,
Volume 150, Issue 1, Pages (July 2018)
Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates  N.A. Latif, E.M. Ko,
Volume 130, Issue 1, Pages (July 2013)
Volume 152, Issue 1, Pages (January 2019)
Volume 147, Issue 1, Pages (October 2017)
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.
Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK , an AKT inhibitor, in patients with recurrent or persistent.
Volume 152, Issue 1, Pages (January 2019)
The complex interaction of cancer surgery, complications, and patient-reported outcomes: A single score is not enough  K.M. Doll, E.L. Barber, J.T. Bensen,
Volume 142, Issue 2, Pages (August 2016)
Annika Idahl, Andrea Hermansson, Ann Lalos  Gynecologic Oncology 
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study 
Volume 152, Issue 1, Pages (January 2019)
Volume 130, Issue 1, Pages (July 2013)
Full inguinofemoral lymphadenectomy after positive sentinel inguinofemoral lymph node is associated with greater overall survival in patients with stage.
Volume 152, Issue 1, Pages (January 2019)
Volume 130, Issue 3, Pages (September 2013)
Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer  M. Dandapani, B.L. Seagle, R. Samuelson,
Pulmonary Resection for Metastases from Colorectal Cancer
Characteristics of primary peritoneal serous carcinoma in a U. S
Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.
High-risk cancer, unequal care: Disparities in the complete surgical staging of high- grade endometrial cancer in the Southeastern United States  J.R.
Should ovarian preservation be considered for women younger than 60 years with endometrial carcinoma?  L.M. Bean, K. Taylor, K.M. Anderson, M.A. Davis,
Volume 54, Issue 1, Pages (July 2008)
Volume 115, Issue 1, Pages (October 2009)
Razvan Diaconescu, MD, Chantal Lafond, MD, Renaud Whittom, MD 
Volume 154, Issue 1, Pages (July 2019)
Presentation transcript:

Volume 130, Issue 1, Pages 49-53 (July 2013) Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer  S.A. Milgrom, M.A. Kollmeier, N.R. Abu-Rustum, V. Makker, G.J. Gardner, R.R. Barakat, K.M. Alektiar  Gynecologic Oncology  Volume 130, Issue 1, Pages 49-53 (July 2013) DOI: 10.1016/j.ygyno.2013.04.013 Copyright © 2013 The Authors Terms and Conditions

Fig. 1 Outcomes of patients with positive versus negative peritoneal cytology. A. Freedom from relapse; B. disease-specific survival; C. overall survival. Solid line=negative peritoneal cytology; dotted line=positive peritoneal cytology. Gynecologic Oncology 2013 130, 49-53DOI: (10.1016/j.ygyno.2013.04.013) Copyright © 2013 The Authors Terms and Conditions